340
Participants
Start Date
October 31, 2010
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
Alisporivir
ALV 200 mg soft gel capsules administered orally
Peginterferon alfa-2a
PEG 180 μg administered via subcutaneous (s.c.) injection once weekly
Ribavirin
RBV 400 mg (2 x 200 mg tablets) administered orally twice daily (BID)
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Brussels
Novartis Investigative Site, Westmead
Novartis Investigative Site, Kogarah
Novartis Investigative Site, Kingswood
Novartis Investigative Site, Leuven
Novartis Investigative Site, Fitzroy
Novartis Investigative Site, Clayton
Novartis Investigative Center, Greenslopes
Novartis Investigative Site, Ghent
Novartis Investigative Site, Taipei
Weill Cornell Medical Center, New York
Mount Sinai Medical Center, New York
Columbia University Medical Center, New York
Novartis Investigative Site, Torino
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Berlin
Novartis Investigative Site, Marseille
Novartis Investigative Site, Brescia
Novartis Investigative Site, Pavia
Novartis Investigative Site, Hanover
Novartis Investigative Site, Bologna
Novartis Investigative Site, Taichung
Novartis Investigative Site, Chiang Mai
Novartis Investigative Site, Frankfurt
Saint Louis University, St Louis
Cotton O'Neil Clinical Research, Topeka
Novartis Investigative Site, Paris
The North Texas Research Institute, Arlington
Liver Associates of Texas, Houston
Liver Specialist of Texas, Houston
Alamo Medical Research, San Antonio
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Niaosong Township
Novartis Investigative Site, Songkhla
Scripps Clinic, La Jolla
Sharp Rees-Stealy Medical Group, Inc., San Diego
Research and Education Inc., San Diego
Novartis Investigative Site, Clichy
Island View Gastroenterology Associates, Ventura
Novartis Investigative Site, Créteil
Hawai Medical Center East LLC, Honolulu
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Haryāna
Novartis Investigative Site, Ludhiana
Novartis Investigative Site, Lucknow
Novartis Investigative Site, Mumbai
Novartis Investigative Site, Mumbai
Novartis Investigative Site, Hyderabad - Andhra Pradesh
Novartis Investigative Site, Trivandrum
Novartis Investigative Site, Guwahati
The Office of Dr. Claudia Martorell, Springfield
Dartmouth-Hitchcock Medical Center, Lebanon
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Toronto
Novartis Investigative Site, Leipzig
Novartis Inestigative Site, Roma
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Lódz
Novartis Investigative Site, Warsaw
Fundacion de Investigacion de Diego, San Juan
Novartis Korea Ltd., Seoul
Novartis Inestigative Center, Pusan
Novartis Investigative Site, Pusan
Novartis Investigative Site, Seoul
Novartis Investigative Site, Douliu
Novartis Investigative Site, Taipei
Novartis Investigative Site, Glasgow - Scotland
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Plymouth
Lead Sponsor
Debiopharm International SA
INDUSTRY